Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage

Archives of Pharmacal Research

Volumn 34, Issue 5, 2011, Pages 767-774

  Parveen, Rabea ^a   Baboota, Sanjula ^a   Ali, Javed ^a   Ahuja, Alka ^a   Vasudev, Suruchi S ^a   Ahmad, Sayeed ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Carbon tetrachloride; Hepatic damage; Nanoemulsion; Silymarin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBON TETRACHLORIDE; GLOBULIN; GLUTATHIONE; LIPID PEROXIDE; SILYMARIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HISTOPATHOLOGY; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; NANOEMULSION; NONHUMAN; OXIDATIVE STRESS; RAT; WISTAR RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; CARBON TETRACHLORIDE; DRUG CARRIERS; DRUG-INDUCED LIVER INJURY; EMULSIONS; FEMALE; GLUTATHIONE; LIPID PEROXIDES; LIVER; NANOSTRUCTURES; OXIDANTS; OXIDATION-REDUCTION; PHYTOTHERAPY; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SILYMARIN; SOLUBILITY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 79960244886     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0510-8     Document Type: Article

References (53)

1. A. A. Attama I. T. Nzekwe P. O. Nnamani M. U. Adikwu C. O. Onugu 2003 The use of solid self-emulsifying systems in the delivery of diclofenac Int. J. Pharm. 262 23 28 12927384 10.1016/S0378-5173(03)00315-6 1:CAS:528: DC%2BD3sXmtFaluro%3D (Pubitemid 36966690)
2. F. Barbarino E. Neumann I. Deaciuc N. W. Ghelberg A. Suciu C. Cotutiu L. Racovitça C. Stroilça S. Nagy N. Pçarçau S. Toader C. Brilinschi 1981 Effect of silymarin on experimental liver lesions Med. Interne 19 347 357 7336095 1:CAS:528:DyaL38XhtlGrtL0%3D (Pubitemid 12141684)
3. O. A. Bessey O. H. Lowry M. J. Brock 1964 A method for the rapid determination of alkaline phosphates with five cubic millimeters of serum J. Biol. Chem. 164 321 329
4. A. Comoglio A. Tomasi S. Malandrino G. Poli E. Albano 1995 Scavenging effect of silipide, a new silybinphospholipid complex, on ethanol-derived free radicals Biochem. Pharmacol. 50 1313 1316 7488251 10.1016/0006-2952(95)02001-S 1:CAS:528:DyaK2MXptFyrsb0%3D
5. M. Comporti E. Maellaro B. Del Bello A. F. Casini 1991 Glutathione depletion: its effects on other antioxidant systems and hepatocellular damage Xenobiotica 21 1067 1076 1776277 10.3109/00498259109039546 1:CAS:528: DyaK3MXmtVSmt7s%3D
6. P. P. Constantinides 1995 Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm. Res. 12 1561 1572 8592652 10.1023/A:1016268311867 1:CAS:528:DyaK2MXpslCqsrs%3D (Pubitemid 26005509)
7. J. C. Davila A. Lenherr D. Acosta 1989 Protective effect of flavonoids on drug-induced hepatotoxicity in vitro Toxicology 57 267 286 2756528 10.1016/0300-483X(89)90116-9 1:CAS:528:DyaL1MXlt1ymtr8%3D (Pubitemid 19188276)
8. A. Desplaces J. Choppin G. Vogel W. Trost 1975 The effects of silymarin on experimental phalloidine poisoning Arzneimittelforschung 25 89 96 125090 1:CAS:528:DyaE2MXkt1ehs7s%3D
9. G. L. Ellman 1959 Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 70 77 13650640 10.1016/0003-9861(59)90090-6 1:CAS:528:DyaG1MXotl2ksA%3D%3D
10. Y. Z. Fang S. Yang G. Wu 2002 Free radicals, antioxidants, and nutrition Nutrition 18 872 879 12361782 10.1016/S0899-9007(02)00916-4 1:CAS:528: DC%2BD38XnsVahtLc%3D (Pubitemid 35292261)
11. G. L. Floersheim M. Eberhard P. Tschumi F. Duckert 1978 Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides Toxicol. Appl. Pharmacol. 46 455 462 569913 10.1016/0041-008X(78)90091-1 1:CAS:528:DyaE1MXpvVeitg%3D%3D (Pubitemid 9077614)
12. K. Flora M. Hahn H. Rosen K. Benner 1998 Milk thistle (Silybum marianum) for the therapy of liver disease Am. J. Gastroenterol. 93 139 143 9468229 10.1111/j.1572-0241.1998.00139.x 1:CAS:528:DyaK1cXmt1Grsrk%3D (Pubitemid 29063954)
13. Gadetta, V.; Bombardelli, E.; and Pifferi, G.; Complexes of flavanolignans with phospholipids, preparations thereof and associated pharmaceutical compositions. U. S. Patent, 4764508 (1988).
14. Galighter, A. E. and Koyloff, E. N.; Essential of Practical Microtechnique, Lea and Febiger, Philadelphia, (1971).
15. S. Giacomelli D. Gallo P. Apollonio C. Ferlini M. Distefano P. Morazzoni A. Riva E. Bombardelli S. Mancuso G. Scambia 2002 Silybin and its bioavailable phospholipid complex (IdB1016) potentiate in vitro and in vivo activity of cisplatin Life Sci. 70 1447 1459 11883719 10.1016/S0024-3205(01)01511-9 1:CAS:528:DC%2BD38XhsFSkurk%3D (Pubitemid 34159100)
16. P. D. Hall J. L. Plummer A. H. Ilsley M. J. Cousins 1991 Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat Hepatology 13 815 819 2029987 10.1016/0270-9139(91)90246-R 1:CAS:528:DyaK3MXkt1Ciu7Y%3D
17. S. Javed K. Kohli M. Ali 2010 Patented bioavailability enhancement techniques of silymarin Recent Pat. Drug Deliv. Formul. 4 145 152 20156178 10.2174/187221110791184999 1:CAS:528:DC%2BC3cXms1Sjsrk%3D
18. D. E. Johnston C. Kroening 1998 Mechanism of early carbon tetrachloride toxicity in cultured rat hepatocytes Pharmacol. Toxicol. 83 231 239 9868740 10.1111/j.1600-0773.1998.tb01475.x 1:CAS:528:DyaK1cXnvFyjtLw%3D (Pubitemid 28559517)
19. N. Kaplowitz T. Y. Aw F. R. Simon A. Stolz 1986 Druginduced hepatotoxicity Ann. Intern. Med. 104 826 839 3518564 1:STN:280: DyaL283htlCnsg%3D%3D
20. S. Khandavilli R. Panchagnula 2007 Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats J. Invest. Dermatol. 127 154 162 16858422 10.1038/sj.jid.5700485 1:CAS:528:DC%2BD28XhtlSqurnI (Pubitemid 46005673)
21. S. R. Kingsley S. J. Frankel 1939 The determination of serum total protein albumin and globulin by the biuret reaction J. Biol. Chem. 128 131 137
22. A. Kogan A. Aserin N. Garti 2007 Improved solubilization of carbamazepine and structural transitions in nonionic microemulsions upon aqueous phase dilution J. Colloid Interface Sci. 315 637 647 17825310 10.1016/j.jcis.2007.06. 087 1:CAS:528:DC%2BD2sXhtV2ru7nL (Pubitemid 47454616)
23. P. Kosina V. Kren R. Gebhardt F. Grambal J. Ulrichová D. Walterová 2002 Antioxidant properties of silybin glycosides Phytother. Res. 16 S33 S39 11933137 10.1002/ptr.796 1:CAS:528:DC%2BD38Xjt1Wrsbc%3D
24. B. H. Lauterburg 2002 Analgesics and glutathione Am. J. Ther. 9 225 233 11941382 10.1097/00045391-200205000-00008
25. M. J. Lawrence G. D. Rees 2000 Microemulsion-based media as novel drug delivery systems Adv. Drug Deliv. Rev. 45 89 121 11104900 10.1016/S0169-409X(00) 00103-4 1:CAS:528:DC%2BD3cXosFertb4%3D
26. M. H. Lee H. Y. Lin H. C. Chen J. L. Thomas 2008 Ultrasound mediates the release of curcumin from microemulsions Langmuir 4 1707 1713 10.1021/la7022874 (Pubitemid 351500922)
27. Madaus, R.; Halbach, G.; and Trost, W.; Salt of silymarin group with aminopolyhydroxy alcohols. U. S. Patent, 3994925 (1976).
28. H. T. Mallory K. A. Evelyn 1937 The determination of bilirubin with photoelectric colorimeter J. Biol. Chem. 119 481 490
29. K. A. Mereish D. L. Bunner D. R. Ragland D. A. Creasia 1991 Protection against microcystin-LR-induced hepatotoxicity by silymarin: biochemistry, histopathology, and lethality Pharm. Res. 8 273 277 1902564 10.1023/A: 1015868809990 1:CAS:528:DyaK3MXhtFGjt70%3D
30. P. Morazzoni E. Bombardelli 1994 Silybum marianum (Carduus marianus) Fitoterapia 66 3 42
31. P. Muriel M. Mourelle 1990 Prevention by silymarin of membrane alterations in acute CCl4 liver damage J. Appl. Toxicol. 10 275 279 1975258 10.1002/jat.2550100408 1:CAS:528:DyaK3cXlsVKrtbY%3D (Pubitemid 20269790)
32. P. Muriel T. Garciapiña V. Perez-Alvarez M. Mourelle 1992 Silymarin protects against paracetamol-induced lipid peroxidation and liver damage J. Appl. Toxicol. 12 439 442 1360480 10.1002/jat.2550120613 1:CAS:528: DyaK3sXhs1aktA%3D%3D
33. H. Najafzadeh M. R. Jalali H. Morovvati F. Taravati 2010 Comparison of the prophylactic effect of silymarin and deferoxamine on iron overload-induced hepatotoxicity in rat J. Med. Toxicol. 6 22 26 20182837 10.1007/s13181-010-0030- 9 1:CAS:528:DC%2BC3cXovFOitL0%3D
34. J. Pepping 1999 Milk thistle: Silybum marianum Am. J. Health Syst. Pharm. 56 1195 1197 10484652 1:STN:280:DyaK1MzhsV2nsA%3D%3D
35. S. J. Polyak C. Morishima V. Lohmann S. Pal D. Y. Lee Y. Liu T. N. Graf N. H. Oberlies 2010 Identification of hepatoprotective flavonolignans from silymarin Proc. Natl. Acad. Sci. U. S. A. 107 5995 5999 20231449 10.1073/pnas.0914009107 1:CAS:528:DC%2BC3cXks1KktL8%3D
36. W. R. Porter R. A. Neal 1978 Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes Drug Metab. Dispos. 6 379 388 28917 1:CAS:528:DyaE1MXhtFyr (Pubitemid 8399686)
37. C. W. Pouton C. J. H. Porter 2008 Formulation of lipidbased delivery systems for oral administration: materials, methods and strategies Adv. Drug Deliv. Rev. 60 625 637 18068260 10.1016/j.addr.2007.10.010 1:CAS:528: DC%2BD1cXitVOnu7s%3D
38. S. C. Pradhan C. Girish 2006 Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine Indian J. Med. Res. 124 491 504 17213517 1:CAS:528:DC%2BD2sXjtlKjtLs%3D (Pubitemid 46157708)
39. F. Rainone 2005 Milk thistle Am. Fam. Physician 72 1285 1288 16225032 (Pubitemid 43104260)
40. R. O. Recknagel E. A. Glende Jr. J. A. Dolak R. L. Waller 1989 Mechanisms of carbon tetrachloride toxicity Pharmacol. Ther. 43 134 154 10.1016/0163-7258(89)90050-8
41. S. Reitman S. Frankel 1957 A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases Am. J. Clin. Pathol. 28 56 63 13458125 1:CAS:528:DyaG2sXpvFyiuw%3D%3D
42. H. Schriewer F. Weinhold 1979 The influence of silybin from Silybum marianum (L.) Gaertn. on in vitro phosphatidyl choline biosynthesis in rat livers Arzneimittelforschung 29 791 792 582978 1:CAS:528:DyaE1MXks1ylsrc%3D (Pubitemid 9186625)
43. J. Sedlak R. H. Lindsay 1968 Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent Anal. Biochem. 25 192 205 4973948 10.1016/0003-2697(68)90092-4 1:CAS:528:DyaF1MXhslCktA%3D%3D
44. C. P. Siegers A. Frühling M. Younes 1983 Influence of dithiocarb, (+)-catechin and silybine on halothane hepatotoxicity in the hypoxic rat model Acta Pharmacol. Toxicol. (Copenh) 53 125 129 10.1111/j.1600-0773.1983.tb01879.x 1:CAS:528:DyaL3sXltlemtbc%3D (Pubitemid 13074525)
45. 3 radical J. Biol. Chem. 265 8392 8399 2140358 1:CAS:528:DyaK3cXktVWktLo%3D
46. S. K. Thakur 2002 Silymarin-A hepatoprotective agent Gastroenterol. Today 6 78 82
47. S. B. Tiwari M. M. Amiji 2006 Improved oral delivery of paclitaxel following administration in nanoemulsion formulations J. Nanosci. Nanotechnol. 6 3215 3221 17048539 10.1166/jnn.2006.440 1:CAS:528:DC%2BD28XhtVKnsrrO (Pubitemid 44580003)
48. A. Valenzuela R. Guerra A. Garrido 1987 Silybin dihemisuccinate protects rat erythrocytes against phenylhydrazine-induced lipid peroxidation and hemolysis Planta Med. 53 402 405 3432421 10.1055/s-2006-962757 1:CAS:528:DyaL1cXhs1ehtQ%3D%3D (Pubitemid 17150420)
49. T. K. Vyas A. Shahiwala M. M. Amiji 2008 Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations Int. J. Pharm. 347 93 101 17651927 10.1016/j.ijpharm.2007.06.016 1:CAS:528:DC%2BD2sXhtlOjsrbP (Pubitemid 350180312)
50. Wachter, W. and Zaeske, H.; Process for the manufacture of flavanolignan preparation with improve release and absorbability, compositions obtainable thereby and their use for the preparation of pharmaceuticals. U. S. Patent, 6020384 (2000).
51. M. Wang L. L. Grange J. Tao 1996 Hepatoprotective properties of Silybum marianum herbal formulation on ethanol-induced liver damage Fitoterapia 67 167 171
52. J. S. Woo T. S. Kim J. H. Park S. C. Chi 2007 Formulation and biopharmaceutical evaluation of silymarin using SMEDDS Arch. Pharm. Res. 30 82 89 17328246 10.1007/BF02977782 1:CAS:528:DC%2BD2sXhvVKksro%3D
53. W. Wu Y. Wang L. Que 2006 Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system Eur. J. Pharm. Biopharm. 63 288 294 16527467 10.1016/j.ejpb.2005.12.005 1:CAS:528:DC%2BD28XltFCgsr8%3D (Pubitemid 43776222)